協合高聚生金葡素(HAS) 配合放療治療惡性腫瘤療效分析

來源:超級抗原科普平臺

高聚金葡素(HAS) 配合放療治療惡性腫瘤療效分析

協合超級抗原高聚金葡素(HAS) 配合放療治療惡性腫瘤療效分析

摘要

目的 評價高聚金葡素配合放射治療惡性腫瘤的效果。

方法  1 2 5例惡性腫瘤隨機分為治療組和單放組。治療組于放療前 1天開始肌注或靜滴高聚金葡素 1 0 0 0 u,每日一次 ,4~ 6周為1療程。兩組均采用常規放療。檢測兩組瘤體變化 ,周圍血白細胞 ,T細胞亞群 ,NK,LAK細胞活性。

結果 治療組抑瘤率 ,周圍血 WBC水平 ,T細胞亞群、NK、LAK細胞活性均高于單放組 ,兩組差異顯著。

結論 HAS配合放射治療具有協同、增敏和增強抗癌免疫功能的作用。

Abstract

Objective Appraised the Curative effects of radiotherapy the malignant tumour patients with HAS.Methods 125 cases of the malignant tumour randomly divided into the cure group and the group of single radiotherapy, the 64 cases of cure group began to intramuscular injection by HAS or intravenous drip with 1000u one day before radiotherapy,one time/day;4~6weeks were a course of treatment.The two groups of tumour patients were examined white cell of peripheral blood picture; T cell; the divided of NK、LAK cells of the cure group were higher than the compared group of single radiation the two group had obviou sly different.

Conclusion HAS coordinated with the radio therapy to cure the cancer patiens many functions such as coordinat ion, increasing sen sib ility snd active immunity to cancer.

Key wordsRadio therapy    Malignan t tumor    HAS

關鍵詞 放射治療,   惡性腫瘤,   高聚金葡素   

中圖分類號: R730. 54  文獻標識碼:A   文章編號: 100028578 (2001) 0120052202

2001, Vol. 28 圖片 Issue (01): 52-53    DOI: 10.3971/j.issn.1000-8578.2394

協合超級抗原高聚金葡素(HAS) 配合放療治療惡性腫瘤療效分析

相關科普視頻和閱讀↓

人類健康的新曙光:超級抗原

超級抗原口服液和注射液哪個好?

超級抗原神奇案例大全(部分)

超級抗原科普片

超級抗原臨床案例及論文

超級抗原全球見證

超級抗原科普精選

協合超級抗原高聚金葡素(HAS) 配合放療治療惡性腫瘤療效分析

閱讀19999